Home › Companies › Biohaven Ltd. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Biohaven Ltd.’s Form 8-K, filed May 4, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of April 28, 2026: 5 items on Biohaven Ltd.’s Form 8-K, filed May 4, 2026: 3 elected · 2 approved.
Notable dissent: 3 directors (16.5%, 16.0%, 16.0% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Rubric Capital (13F, 3.2%, as of September 30, 2026)
Explore Biohaven Ltd. in the interactive database Compare manager voting policies
These tallies are Biohaven Ltd.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Michael T. Heffernan | 76,133,746 | 15,092,665 | 1,984,918 | -- | -- | 83% | Elected | — |
| Elect Director: Irina Antonijevic, M.D., Ph.D. | 76,612,017 | 14,616,115 | 1,983,197 | -- | -- | 84% | Elected | — |
| Elect Director: Robert J. Hugin | 76,597,707 | 14,626,151 | 1,987,471 | -- | -- | 84% | Elected | — |
| 2. Ratification of the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026 | 123,723,636 | 214,123 | 1,410,634 | -- | -- | 99.8% | Approved | — |
| 3. Advisory vote on the compensation paid to the Company's named executive officers | 87,521,620 | 4,202,883 | 1,486,826 | -- | -- | 95% | Approved | — |
Source: Biohaven Ltd., Form 8-K, filed with the SEC on May 4, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
276 asset managers disclosed a vote on at least one Biohaven Ltd. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 3 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D.
Biohaven Ltd.’s own tally for this item (“Elect Director: Irina Antonijevic, M.D., Ph.D.”): 76,612,017 for, 14,616,115 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Broker Non-Votes: 32,137,064 All nominees were elected.”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 26,362,767 for, 2,794,453 against, 12,535 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 2,795,342 | 2,211,554 | 0 | 0 | Mixed |
| BlackRock | 4,782,388 | 0 | 0 | 0 | For |
| Fidelity | 4,217,284 | 0 | 0 | 0 | For |
| State Street | 3,582,113 | 0 | 0 | 0 | For |
| Vanguard | 3,469,201 | 80,231 | 3 | 0 | For |
| T. Rowe Price | 1,817,446 | 0 | 0 | 0 | For |
| Capital Group | 1,582,792 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 1,038,365 | 0 | 0 | 0 | For |
| Charles Schwab | 861,954 | 0 | 0 | 0 | For |
| TIAA | 826,690 | 0 | 0 | 0 | For |
| Equitable | 228,357 | 0 | 0 | 0 | For |
| JPMorgan | 206,961 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 153,564 | 0 | 0 | 0 | For |
| EA Series Trust | 148,520 | 0 | 0 | 0 | For |
| Lincoln Financial | 99,607 | 19,130 | 0 | 0 | Mixed |
| ProShares | 0 | 94,572 | 0 | 0 | Against |
| Brighthouse | 62,835 | 30,945 | 0 | 0 | Mixed |
| Goldman Sachs | 73,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 64,173 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 62,516 | 0 | 0 | Against |
| John Hancock | 31,509 | 27,892 | 0 | 0 | Mixed |
| Roundhill ETF Trust | 0 | 53,413 | 0 | 0 | Against |
| Northern Trust | 49,313 | 0 | 0 | 0 | For |
| Global X | 43,164 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 42,502 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
83% Majority: yes · of votes cast
Description as filed by funds: Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan
Biohaven Ltd.’s own tally for this item (“Elect Director: Michael T. Heffernan”): 76,133,746 for, 15,092,665 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Broker Non-Votes: 32,137,064 All nominees were elected.”
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 26,344,014 for, 2,813,206 against, 12,535 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 2,795,342 | 2,211,554 | 0 | 0 | Mixed |
| BlackRock | 4,782,388 | 0 | 0 | 0 | For |
| Fidelity | 4,217,284 | 0 | 0 | 0 | For |
| State Street | 3,582,113 | 0 | 0 | 0 | For |
| Vanguard | 3,473,530 | 75,902 | 3 | 0 | For |
| T. Rowe Price | 1,817,446 | 0 | 0 | 0 | For |
| Capital Group | 1,582,792 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 1,038,365 | 0 | 0 | 0 | For |
| Charles Schwab | 861,954 | 0 | 0 | 0 | For |
| TIAA | 826,690 | 0 | 0 | 0 | For |
| Equitable | 228,357 | 0 | 0 | 0 | For |
| JPMorgan | 206,961 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 153,564 | 0 | 0 | 0 | For |
| EA Series Trust | 148,520 | 0 | 0 | 0 | For |
| Lincoln Financial | 99,607 | 19,130 | 0 | 0 | Mixed |
| ProShares | 0 | 94,572 | 0 | 0 | Against |
| Brighthouse | 62,835 | 30,945 | 0 | 0 | Mixed |
| Goldman Sachs | 73,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 64,173 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 62,516 | 0 | 0 | Against |
| John Hancock | 31,509 | 27,892 | 0 | 0 | Mixed |
| Roundhill ETF Trust | 0 | 53,413 | 0 | 0 | Against |
| Northern Trust | 49,313 | 0 | 0 | 0 | For |
| Global X | 43,164 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 42,502 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).
Combines 3 wordings of this item as funds reported it.
84% Majority: yes · of votes cast
Description as filed by funds: Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin
Biohaven Ltd.’s own tally for this item (“Elect Director: Robert J. Hugin”): 76,597,707 for, 14,626,151 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “Broker Non-Votes: 32,137,064 All nominees were elected.”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 26,367,096 for, 2,790,123 against, 12,535 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 2,795,342 | 2,211,554 | 0 | 0 | Mixed |
| BlackRock | 4,782,388 | 0 | 0 | 0 | For |
| Fidelity | 4,217,284 | 0 | 0 | 0 | For |
| State Street | 3,582,113 | 0 | 0 | 0 | For |
| Vanguard | 3,473,530 | 75,901 | 3 | 0 | For |
| T. Rowe Price | 1,817,446 | 0 | 0 | 0 | For |
| Capital Group | 1,582,792 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 1,038,365 | 0 | 0 | 0 | For |
| Charles Schwab | 861,954 | 0 | 0 | 0 | For |
| TIAA | 826,690 | 0 | 0 | 0 | For |
| Equitable | 228,357 | 0 | 0 | 0 | For |
| JPMorgan | 206,961 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 153,564 | 0 | 0 | 0 | For |
| EA Series Trust | 148,520 | 0 | 0 | 0 | For |
| Lincoln Financial | 99,607 | 19,130 | 0 | 0 | Mixed |
| ProShares | 0 | 94,572 | 0 | 0 | Against |
| Brighthouse | 62,835 | 30,945 | 0 | 0 | Mixed |
| Goldman Sachs | 73,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 64,173 | 0 | 0 | Against |
| Direxion Shares ETF Trust | 0 | 62,516 | 0 | 0 | Against |
| John Hancock | 31,509 | 27,892 | 0 | 0 | Mixed |
| Roundhill ETF Trust | 0 | 53,413 | 0 | 0 | Against |
| Northern Trust | 49,313 | 0 | 0 | 0 | For |
| Global X | 43,164 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 42,502 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).
Combines 11 wordings of this item as funds reported it.
95% Approved · of votes cast
Prior year: 85.9% for (May 5, 2025 meeting) ▲ 9.5 pts
Description as filed by funds: A non-binding advisory vote on the compensation of the Company's named executive officers.
Biohaven Ltd.’s own tally for this item (“3. Advisory vote on the compensation paid to the Company's named executive officers”): 87,521,620 for, 4,202,883 against — passed, per its Form 8-K filed May 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 3: Advisory vote on the compensation paid to the Company's named executive officers.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 5,006,896 | 0 | 0 | 0 | For |
| BlackRock | 4,782,388 | 0 | 0 | 0 | For |
| Fidelity | 4,217,284 | 0 | 0 | 0 | For |
| State Street | 3,582,113 | 0 | 0 | 0 | For |
| Vanguard | 3,537,055 | 12,377 | 3 | 0 | For |
| T. Rowe Price | 1,817,446 | 0 | 0 | 0 | For |
| Capital Group | 0 | 1,582,792 | 0 | 0 | Against |
| Simplify Exchange Traded Funds | 1,038,365 | 0 | 0 | 0 | For |
| Charles Schwab | 861,954 | 0 | 0 | 0 | For |
| TIAA | 826,690 | 0 | 0 | 0 | For |
| Equitable | 228,357 | 0 | 0 | 0 | For |
| JPMorgan | 206,961 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 153,564 | 0 | 0 | 0 | For |
| EA Series Trust | 148,520 | 0 | 0 | 0 | For |
| Lincoln Financial | 118,737 | 0 | 0 | 0 | For |
| ProShares | 94,572 | 0 | 0 | 0 | For |
| Brighthouse | 93,780 | 0 | 0 | 0 | For |
| Goldman Sachs | 73,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 64,173 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 62,516 | 0 | 0 | 0 | For |
| John Hancock | 59,401 | 0 | 0 | 0 | For |
| Roundhill ETF Trust | 53,413 | 0 | 0 | 0 | For |
| Northern Trust | 49,313 | 0 | 0 | 0 | For |
| Global X | 43,164 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 42,502 | 0 | 0 | 0 | For |
Fund voting reports, all 56 managers: 27,541,161 for, 1,615,939 against, 12,535 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Janus Henderson | 33,681,007 | 40,486 | 0 | 0 | For |
| 1919 Investment Counsel, LLC | 9,793,588 | 0 | 0 | 0 | For |
| MONTANOVA CAPITAL, LLC | 8,597,649 | 0 | 0 | 0 | For |
| State Street | 5,468,300 | 22,899 | 0 | 0 | For |
| BlackRock | 4,943,225 | 20,341 | 0 | 0 | For |
| T. Rowe Price | 2,541,831 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 2,465,861 | 0 | 0 | 0 | For |
| Fidelity | 2,299,412 | 0 | 0 | 0 | For |
| DE Shaw | 1,605,153 | 0 | 0 | 0 | For |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,500,000 | 0 | 0 | 0 | For |
| AQR | 1,465,324 | 0 | 0 | 0 | For |
| Cormorant Asset Management, LP | 1,440,995 | 0 | 0 | 0 | For |
| Capital Research Global Investors | 0 | 1,332,792 | 0 | 0 | Against |
| Two Sigma | 1,067,279 | 0 | 0 | 0 | For |
| Vanguard | 870,173 | 0 | 0 | 0 | For |
| Charles Schwab | 862,352 | 0 | 0 | 0 | For |
| DAFNA Capital Management LLC | 845,735 | 0 | 0 | 0 | For |
| Nuveen | 840,669 | 0 | 0 | 0 | For |
| 5AM Venture Management, LLC | 738,972 | 0 | 0 | 0 | For |
| Kynam Capital Management, LP | 0 | 0 | 0 | 702,884 | Withhold |
| Northern Trust | 679,837 | 14,372 | 0 | 0 | For |
| Aberdeen | 0 | 693,452 | 0 | 0 | Against |
| Integral Health Asset Management, LLC | 664,094 | 0 | 0 | 0 | For |
| BALYASNY ASSET MANAGEMENT L.P. | 523,095 | 0 | 0 | 0 | For |
| Fiera Capital Corp | 418,470 | 19,214 | 0 | 0 | For |
Institutional-manager reports, all 234 managers: 86,798,763 for, 3,405,867 against, 702,884 withheld, 207,373 abstained, 852 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Prior year: 99.9% for (May 5, 2025 meeting) ▼ 0.1 pts
Description as filed by funds: RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR FISCAL YEAR 2026.
Biohaven Ltd.’s own tally for this item (“2. Ratification of the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026”): 123,723,636 for, 214,123 against — passed, per its Form 8-K filed May 4, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Broker Non-Votes: 0 Proposal No. 2 was approved.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 57 asset managers below reported 29,157,220 for, 12,535 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| JANUS INVESTMENT FUND | 5,006,896 | 0 | 0 | 0 | For |
| BlackRock | 4,782,388 | 0 | 0 | 0 | For |
| Fidelity | 4,217,284 | 0 | 0 | 0 | For |
| State Street | 3,582,113 | 0 | 0 | 0 | For |
| Vanguard | 3,549,432 | 0 | 3 | 0 | For |
| T. Rowe Price | 1,817,446 | 0 | 0 | 0 | For |
| Capital Group | 1,582,792 | 0 | 0 | 0 | For |
| Simplify Exchange Traded Funds | 1,038,365 | 0 | 0 | 0 | For |
| Charles Schwab | 861,954 | 0 | 0 | 0 | For |
| TIAA | 826,690 | 0 | 0 | 0 | For |
| Equitable | 228,357 | 0 | 0 | 0 | For |
| JPMorgan | 206,961 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 153,564 | 0 | 0 | 0 | For |
| EA Series Trust | 148,520 | 0 | 0 | 0 | For |
| Lincoln Financial | 118,737 | 0 | 0 | 0 | For |
| ProShares | 94,572 | 0 | 0 | 0 | For |
| Brighthouse | 93,780 | 0 | 0 | 0 | For |
| Goldman Sachs | 73,266 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 64,173 | 0 | 0 | 0 | For |
| Direxion Shares ETF Trust | 62,516 | 0 | 0 | 0 | For |
| John Hancock | 59,401 | 0 | 0 | 0 | For |
| Roundhill ETF Trust | 53,413 | 0 | 0 | 0 | For |
| Northern Trust | 49,313 | 0 | 0 | 0 | For |
| Global X | 43,164 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 42,502 | 0 | 0 | 0 | For |
Showing the 25 largest of 57 asset managers. All 57 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 150,506,490 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | JANUS INVESTMENT FUND | 3.33% |
| 2 | BlackRock | 3.18% |
| 3 | Fidelity | 2.80% |
| 4 | State Street | 2.38% |
| 5 | Vanguard | 2.36% |
| 6 | T. Rowe Price | 1.21% |
| 7 | Capital Group | 1.05% |
| 8 | Simplify Exchange Traded Funds | 0.69% |
| 9 | Charles Schwab | 0.57% |
| 10 | TIAA | 0.55% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Janus Henderson | 22.41% |
| 2 | 1919 Investment Counsel, LLC | 6.51% |
| 3 | MONTANOVA CAPITAL, LLC | 5.71% |
| 4 | State Street | 3.65% |
| 5 | BlackRock | 3.30% |
| 6 | T. Rowe Price | 1.69% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 1.64% |
| 8 | Fidelity | 1.53% |
| 9 | DE Shaw | 1.07% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.00% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 11,222,407 | 7.46% | Form 13F, quarter ended March 31, 2026 |
| Suvretta Capital Management, LLC | 10,286,937 | 6.83% | Proxy statement (DEF 14A), proxy filed March 13, 2026 |
| John Childs | 10,071,227 | 6.69% | Proxy statement (DEF 14A), proxy filed March 13, 2026 |
| JANUS HENDERSON GROUP Ltd. | 8,584,676 | 5.70% | Schedule 13G, filed July 8, 2026 |
| Woodline Partners LP | 7,660,280 | 5.09% | Schedule 13G, filed August 14, 2026 |
| State Street | 6,618,803 | 4.40% | Form 13F, quarter ended March 31, 2026 |
| Vlad Coric, M.D. | 5,483,354 | 3.64% | Proxy statement (DEF 14A), proxy filed March 13, 2026 |
| Vanguard Group | 4,395,946 | 2.92% | Form 13F, quarter ended March 31, 2026 |
| D.E. Shaw | 2,847,193 | 1.89% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 2,513,181 | 1.67% | Form 13F, quarter ended March 31, 2026 |
Percentages above are of 150,506,490 shares outstanding, as reported by Biohaven Ltd. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Biohaven Ltd.'s shareholder meeting held April 28, 2026, in the 2025-2026 proxy season, 276 asset managers reported votes on at least one of its 5 ballot items in their SEC Form N-PX filings, covering 1,285 separate fund positions. On the most widely held item on that ballot — A non-binding advisory vote on the compensation of the Company's named executive officers. — Biohaven Ltd.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Biohaven Ltd.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 4, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Biohaven Ltd.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Biohaven Ltd. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Biohaven (BHVN) 2026 Annual Meeting: Vote Results & How Funds Voted”, https://proxyvotesnow.com/company/biohaven-ltd/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.